What is he best known for?
The fields of study he is best known for:
- Virus
- Internal medicine
- Gene
The scientist’s investigation covers issues in Immunology, Virology, Dengue virus, Dengue fever and Vaccination.
His studies examine the connections between Immunology and genetics, as well as such issues in Internal medicine, with regards to Vaccine efficacy.
His Virology research is multidisciplinary, relying on both Antibody and Immunogenicity.
As part of one scientific family, he deals mainly with the area of Dengue virus, narrowing it down to issues related to the Flavivirus, and often Flaviviridae, Attenuated vaccine and Cellular immunity.
His studies in Dengue fever integrate themes in fields like Cytokine, Interferon gamma, Serotype and Japanese encephalitis.
Bruce L. Innis interconnects Hepatitis B vaccine, Booster dose, Hepatitis A vaccine, Reactogenicity and Seroconversion in the investigation of issues within Vaccination.
His most cited work include:
- Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis (1517 citations)
- Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial (1474 citations)
- Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity (1287 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Virology, Immunology, Virus, Dengue virus and Vaccination.
His research in Virology intersects with topics in Antibody and Hepatitis E virus.
In Immunology, Bruce L. Innis works on issues like Internal medicine, which are connected to Vaccine efficacy and Influenza vaccine.
His Virus research incorporates elements of Immunization and Immune system.
His study in Dengue virus is interdisciplinary in nature, drawing from both Viremia and Neutralizing antibody.
His work carried out in the field of Vaccination brings together such families of science as Titer, Booster dose, Adverse effect, AS03 and Influenza A virus.
He most often published in these fields:
- Virology (62.44%)
- Immunology (40.72%)
- Virus (31.67%)
What were the highlights of his more recent work (between 2017-2021)?
- Virus (31.67%)
- Virology (62.44%)
- Clinical trial (5.43%)
In recent papers he was focusing on the following fields of study:
Bruce L. Innis mainly investigates Virus, Virology, Clinical trial, Pediatrics and Immune system.
His studies deal with areas such as Adjuvant and Antibody, Immunization as well as Virus.
Bruce L. Innis has researched Virology in several fields, including AS03 and Antigen.
His Clinical trial research includes themes of Randomized controlled trial and Cohort.
His Immune system study is concerned with the field of Immunology as a whole.
His Dengue virus research is multidisciplinary, incorporating perspectives in Microneutralization Assay, Inactivated vaccine and Cell mediated immunity.
Between 2017 and 2021, his most popular works were:
- Safety of AS03-adjuvanted influenza vaccines: A review of the evidence. (31 citations)
- Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines (28 citations)
- Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons (27 citations)
In his most recent research, the most cited papers focused on:
- Virus
- Internal medicine
- Gene
Bruce L. Innis mainly focuses on Virology, Virus, Dengue fever, Vaccination and Cohort.
The various areas that Bruce L. Innis examines in his Virology study include AS03 and Immunogenicity.
His Virus research is multidisciplinary, incorporating elements of Adjuvant, Severe acute respiratory syndrome coronavirus 2, Antibody and Chimera.
Bruce L. Innis combines subjects such as Public health, Inactivated vaccine, Antibody titer and Intensive care medicine with his study of Dengue fever.
His Vaccination study combines topics from a wide range of disciplines, such as Dengue vaccine, Humoral immunity, Immune system, Licensure and Target population.
His work investigates the relationship between Cohort and topics such as Vaccine efficacy that intersect with problems in Varicella zoster virus, Disease severity, Vaccine strain and Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
